Anna Randag

Mrs. Anna Randag


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ARAnna Randag
Anna Randag
JRJeroen van Rooij
Jeroen van Rooij
AGArnoud T. van Goor
Arnoud T. van Goor
SVSamuël Verkerk
Samuël Verkerk
RWRobert Wisse
Robert Wisse
CECathrien A. Eggink
Cathrien A. Eggink
To evaluate the incidence of Acanthamoeba keratitis in the Netherlands between 2009 and 2015 and to analyse predicting factors for treatment outcome. Patient characteristics, diagnostic methods, diagnostic delay, therapy prior to and after diagnosis, and visual outcome were obtained from medical files of all patients diagnosed with Acanthamoeba keratitis in the Netherlands between 2009 and 2015. A logistic regression analysis on treatment failure, defined as a best corrected visual acuity of less than 20/40 Snellen decimals (i.e. >0.3 logMAR or an approximate loss of three lines of visual acuity) and/or the need for keratoplasty, was performed to determine predicting factors. Two hundred and twenty-four eyes of 224 patients were included. Ninety-five percent of the patients were contact lens wearers, of whom 74% wore soft contact lenses. The number of cases increased from 16 in 2009 to 49 in 2015. This resulted in an estimated incidence of 1 in 21,000 for soft contact lens wearers in 2015. Eighty-seven eyes (39%) met the criteria for treatment failure. In a multivariable regression analysis, higher age at presentation, a higher severity stage and corticosteroid use before diagnosis were positively correlated with treatment failure. Early referral to a cornea specialist was associated with better clinical outcomes. Although Acanthamoeba keratitis is still a relatively uncommon disease, the incidence in soft contact lens wearers has increased to reach 1 in 21,000 in 2015. Treatment failure occurred in 39% of cases, with age, higher severity stage, corticosteroid use before diagnosis and indirect referral to a cornea specialist as important risks factors.

29 January 2023 in Pathogens
Verified
Journal Article
Open access
PDF file
ARAnna Randag
Anna Randag
LKLieke de Kroon
Lieke de Kroon
HOHenny Otten
Henny Otten
CCCindy Arias Claro-Handgraaf
Cindy Arias Claro-Handgraaf
BSBarbara Schimmer
Barbara Schimmer
FSFoekje Francina Stelma
Foekje Francina Stelma
Acanthamoeba keratitis is almost universally associated with contact lens (CL) use. Until today, however, CL solution manufacturing protocols lack testing of anti-amoebic activity. This study investigates the effectiveness of CL solutions available on the Dutch market against trophozoites and cysts of Acanthamoeba castellanii and Acanthamoeba polyphaga. Sixteen CL solutions were tested: 13 multiple purpose solutions (MPS), 2 hydrogen peroxidase solutions (HPS) and 1 povidone-iodine-based solution (PIS). The Spearman–Karber (SK) log reduction method and an XTT colorimetric assay were used to evaluate the effectiveness at the manufacturer’s minimum recommended disinfection time (MMRDT) and after eight hours. At the MMRDT, one MPS showed an SK mean log reduction (MLR) of >3.0 against A. castellanii trophozoites. Two additional MPS and both HPS reached this threshold after eight hours. The SK MLR values for A. polyphaga trophozoites were between 1 and 3 at all time points. Using the XTT colorimetric assay, only HPS 1 showed >99.9% reduction (equivalent to 3 log reduction) in metabolic activity of A. castellanii trophozoites after eight hours. For A. polyphaga, both HPS and PIS showed a metabolic reduction of >99.9% after eight hours. Cysts were resistant against all solutions. We conclude that following the manufacturer’s guidelines, few solutions provide sufficient effectiveness against Acanthamoeba trophozoites and none against cysts. The results underline the importance of adequate hygiene when handling CLs.

16 September 2022 in Research Square
Verified
Preprint
Open access
PDF file
LKLieke Kroon
Lieke Kroon
ARAnna Randag
Anna Randag
HOHenny Otten
Henny Otten
BSBarbara Schimmer
Barbara Schimmer
MTMarlou Tehupeiory-Kooreman
Marlou Tehupeiory-Kooreman
FSFoekje Francina Stelma
Foekje Francina Stelma
Background To date no standardized methods are used in order to assess the amoebicidal efficacy of commercial contact lens solutions for both trophozoites and cysts of Acanthamoeba species. Here we present two methods that are suitable for this purpose: The Spearman-Karber log reduction method and XTT colorimetric assay. Methods Acanthamoeba castellanii (ATCC 50370) and A. polyphaga (ATCC 30461) trophozoites were cultured in peptone-yeast extract-glucose medium. Cysts were developed in Neff’s encystement medium for 1 week. Spearman-Karber and XTT colorimetric assay were used to evaluate trophozoite and cystocidal efficacy of multi-purpose contact lens solutions (MPS). Results With trophozoites, the Spearman-Karber method gave a log reduction estimate of morphological kill between log 0,83 and log 3,61 of the various contact lens solutions, enabling the differentiation between efficacious and less efficacious solutions. With cysts the maximum log reduction of 2,17 was achieved for all 3 MPS solutions at 8 hours. The XTT colorimetric assay showed reduction in trophozoite metabolic rates between 50 and 100% as provided by an optical density signal. All lens fluid solution with a reduction rate > 90% showed residual growth of Acanthamoeba after one week of incubation on nutrient agar covered with Enterobacter aerogenes. Conclusion Both methods give reproducible estimates of amoebicidal efficacy of contact lens solutions, however, XTT colorimetric assay should be followed by an assay for residual growth to test for viable cysts.

5 March 2026 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
ARAnna Randag
Anna Randag
GVGeorges Mgm Verjans
Georges Mgm Verjans
LRLies Remeijer
Lies Remeijer
Herpes simplex virus type 1 (HSV-1), one of the human herpesviruses, is a frequent cause of recurrent ocular infections. Treatment primarily relies on nucleoside analogues, such as aciclovir (ACV), with or without topical corticosteroids. Treatment failure may be attributed to non-adherence to therapy or inadequate topical corticosteroid dosing, and to a lesser extent to an incorrect diagnosis, coinfection with non-viral pathogens or therapy resistance. ACV resistance (ACV R ) is relatively rare compared with other reasons for treatment failure, but has been documented in 6% of immunocompetent patients with HSV-1 keratitis. ACV R limits the prophylactic and therapeutic efficacy of nucleoside analogues, potentially leading to clinically refractory disease. In this review, we will address the normal pathogenesis of HSV-1 keratitis, the definition and causes of treatment failure in HSV-1 keratitis, a work-up algorithm to be used in the event of treatment failure, the effect of current treatment regimens on the development of ACV R keratitis and treatment options for ACV R keratitis.

1 March 2025 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
ARAnna Randag
Anna Randag
LWLiesbeth Wellens
Liesbeth Wellens
NKNelly Kazemian
Nelly Kazemian
BSBarbara Schimmer
Barbara Schimmer
JRJeroen van Rooij
Jeroen van Rooij
Introduction: During the COVID-19 pandemic, there was a significant decline in the number of patients with both non-urgent and urgent ophthalmologic conditions presenting to emergency departments, leading to concerns about the whereabouts of patients in need of care. We hypothesized that there was an actual decrease in microbial keratitis (MK) cases, due to reduced contact lens (CL) wear and improved hand hygiene, including alcohol-based hand disinfection. Besides, we questioned if non-pharmaceutical interventions would have a sustained effect after the COVID-19 pandemic. Methods: Retrospectively, characteristics of patients presenting with MK at a large ophthalmic tertiary referral center were compared during 9 March– 15 June of 2018 and 2019 (“pre-COVID”), 2020 (“COVID”) and 2022 and 2023 (“post-COVID”). In an online cross-sectional survey among CL wearers, CL wear and hand hygiene habits were compared for the recall months February and April 2020. Results: Three hundred and one MK patients were included: 79 in 2018, 69 in 2019, 41 in 2020, 60 in 2022 and 52 in 2023. Presentation delay was ≥ 4 days in 38% during COVID, compared to 54% pre-COVID (p = 0.106). The proportion of CL related MK did not differ (p = 0.704). Fewer patients were admitted than pre-COVID (p = 0.026), without a difference in admission indications (p = 0.322). Pseudomonas aeruginosa and Staphylococcus aureus cases were not observed during COVID. Post-COVID, MK by Pseudomonas aeruginosa occurred more often than pre-COVID (p < 0.001). In the online survey with 791 respondents, hand washing before CL insertion and removal and hand disinfection were reported more often in April 2020 than February 2020 (respectively, p = 0.001, p < 0.001 and p < 0.001). Conclusion: We found no evidence of MK patients facing barriers to accessing hospital care during the COVID-19 pandemic, as presentation delays were not longer and cases not more severe. Our data suggest that a decreased MK incidence may be due to improved hand hygiene practices, including alcohol-based hand disinfection.

2 July 2026 in Acta Ophthalmologica
Verified
Journal Article
Closed access
LPLaurène Peckeu‐Abboud
Laurène Peckeu‐Abboud
ARAnna Randag
Anna Randag
JRJeroen van Rooij
Jeroen van Rooij
DSDennis Souverein
Dennis Souverein
HOHenny Otten
Henny Otten
BSBarbara Schimmer
Barbara Schimmer